iBody Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 8

iBody General Information

Description

Developer of a monoclonal antibody discovery platform designed to accelerate and enhance the identification of high-value antibodies for therapeutic and diagnostic development. The company offers a proprietary integration of single-cell technology with cell-free antibody expression, enabling pharmaceutical and diagnostic companies to access rare and particular antibodies with increased speed and accuracy.

Contact Information

Website
www.ibody.co.jp/en
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-22-8 Chikusa, Nagoya Life Science Incubator (NALIC)
  • Suite 417, Chikusa-ku
  • Nagoya, Aichi 464-0858
  • Japan
+81
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 2-22-8 Chikusa, Nagoya Life Science Incubator (NALIC)
  • Suite 417, Chikusa-ku
  • Nagoya, Aichi 464-0858
  • Japan
+81

iBody Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iBody Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 04-Aug-2025 Cancelled Generating Revenue
8. Accelerator/Incubator 17-Jul-2026 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
6. Later Stage VC (Series A) 05-Jan-2023 Completed Generating Revenue
5. Accelerator/Incubator 25-Jan-2021 Completed Product Development
4. Accelerator/Incubator Completed Product Development
3. Early Stage VC (Series A1) 31-Jul-2020 Completed Product Development
2. Early Stage VC (Series A) 31-Jul-2020 $4.21M $5.13M Completed Product Development
1. Seed Round 15-May-2018 $918K $918K Completed Startup
To view iBody’s complete valuation and funding history, request access »

iBody Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred B
Preferred A
To view iBody’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

iBody Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

iBody Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024025190-A Paper pattern preparation device, paper pattern preparation method, and computer program Pending 10-Aug-2022

iBody Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iBody Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aichi Deeptech Launchpad Accelerator/Incubator Minority
Beyond Japan Accelerator/Incubator
Central Japan Startup Ecosystem Accelerator/Incubator
Juroku Lease Corporation Minority
TAUNS Laboratories Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

iBody FAQs

  • When was iBody founded?

    iBody was founded in 2018.

  • Where is iBody headquartered?

    iBody is headquartered in Nagoya, Japan.

  • What is the size of iBody?

    iBody has 20 total employees.

  • What industry is iBody in?

    iBody’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is iBody a private or public company?

    iBody is a Private company.

  • What is iBody’s current revenue?

    The current revenue for iBody is .

  • How much funding has iBody raised over time?

    iBody has raised $10.2M.

  • Who are iBody’s investors?

    Aichi Deeptech Launchpad, Beyond Japan, Central Japan Startup Ecosystem, Juroku Lease, and TAUNS Laboratories are 5 of 8 investors who have invested in iBody.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process